Capricor Therapeutics, Inc. (CAPR)
30.12
-0.28
(-0.92%)
USD |
NASDAQ |
Apr 01, 16:00
29.40
-0.72
(-2.39%)
After-Hours: 07:38
Capricor Therapeutics Research and Development Expense (TTM) : 83.50M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | 52.42M |
| Vaxart, Inc. | 201.58M |
| Allogene Therapeutics, Inc. | 137.79M |
| REGENXBIO, Inc. | 212.68M |
| Replimune Group, Inc. | 222.70M |